Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 44,037 shares at $28.17 ($1.3M) on 2016-04-04, disclosed to the SEC on 2016-04-05.
Open-market sale of $1.3M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.17 | 15,203 | $428K | 33.6% |
| 2 | $29.18 | 22,418 | $654K | 51.4% |
| 3 | $29.68 | 6,416 | $190K | 15.0% |
| Total | $28.90 avg | 44,037 | $1.3M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |